Influence of provider factors and race on uptake of breast cancer gene expression profiling.
Katherine E Reeder-HayesStephanie B WheelerChristopher D BaggettXi ZhouKe MengMegan C RobertsLisa A CareyAnne-Marie MeyerPublished in: Cancer (2018)
Provider volume and specialty were found to be significant predictors of GEP use, but did not explain racial disparities in testing. Further research concerning the key contributors to lagging test use among black women is needed to optimize the equitable use of GEPs and support personalized treatment decision making for all patients. Cancer 2018;124:1743-51. © 2018 American Cancer Society.
Keyphrases
- gene expression
- papillary thyroid
- end stage renal disease
- primary care
- decision making
- squamous cell
- ejection fraction
- chronic kidney disease
- dna methylation
- newly diagnosed
- childhood cancer
- prognostic factors
- lymph node metastasis
- healthcare
- pregnant women
- single cell
- metabolic syndrome
- african american
- replacement therapy